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A subset of human peripheral blood lymphocytes is cytolytic for a variety of antibody- 
coated target cells.  This cytotoxic phenomenon occurs without complement (C) and is 
called  antibody-dependent cellular  cytotoxicity (ADCC). J Several points emerge from 
extensive studies of ADCC: (a) The predominant effector lymphocyte is not a T cell and 
does not bear readily detectable amounts of surface-bound immunoglobulin (SIg)  (1-5). 
(b)  Although macrophages are  effector cells  in  some systems  (6,  7),  the  lymphocyte 
effector is nonphagocytic, does not adhere to nylon wool, and does not differentiate into 
macrophage-like cells in culture  (5,  8,  9).  (c)  The effector lymphocyte bears Fc and C 
receptors.  Although  the  interaction  between  the  Fc  receptor  and  Fc  portion  of the 
antibody bound to target cells is required to initiate the cytolytic reaction (9-11), the role, 
if any, of the C receptor in the triggering of ADCC is unknown. 
In a model system using chromium-labeled human lymphocytes and rabbit antihuman 
lymphocyte sera to coat these target cells,  we have previously shown that the ADCC 
effector cell  population in humans can be enriched  and isolated by a  combination of 
separation procedures including: anti-Fab immunoabsorbent column chromatography to 
remove immunoglobulin-bearing B cells, E rosette depletion to remove T cells, and nylon 
adherence  to  remove phagocytic cells  (5,  12). The  resulting  population  which  is  SIg 
negative and E  rosette negative, has been termed "Null" cells.  This subpopulation is 
responsible for most of the ADCC activity present in peripheral human blood.  Further- 
more,  a  subset of this  Null cell  population,  on continued culture,  matures to develop 
surface immunoglobulins and the capacity to secrete immunoglobulins (13). Whether the 
same subset of the Null cell population possesses both ADCC activity and the potential 
for immunoglobulin synthesis, was not determined in these prior studies. 
To resolve this question, we used in the current studies, a  rabbit antiserum 
raised to a  purified glycoprotein complex of mol wt 23,000 and 30,000  (p23,30), 
which was isolated from a  human lymphoblastoid B-cell line (14).  This antise- 
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rum (anti-p23,30) reacts with all SIg-positive B cells and with a subset of human 
Null  cells.  The  serum  does  not  react  with  human  T  cells,  thymocytes,  or 
platelets and has functional properties analogous to murine  anti-Ia  sera  (14). 
Our data show that depletion of p23,30-bearing cells by C-mediated lysis or on 
cellular  immunoabsorbent  columns,  markedly  reduces  ADCC  reactivity  and 
abrogates the production of immunoglobulin in cell culture. Moreover, specific 
binding of anti-p23,30  serum to the cell surface inhibits ADCC. These results 
thus provide evidence that the same Null subset of cells destined to differentiate 
into B cells is responsible for ADCC and, perhaps more importantly, suggest a 
role of Ia antigens in this form of cell-mediated cytotoxicity. 
Materials  and Methods 
Preparation of  Antisera.  The isolation and purification ofp23,30 from the human lymphoblas- 
toid B-cell line IM-1 and the preparation of anti-p23,30 serum is described in the accompanying 
paper (14). This antiserum reacts with all SIg-pesitive B lymphocytes, with virtually no human T 
cells and with approximately 20% of cells within the Ig-negative, E rosette-negative subpopulation 
(Null cells)  (14). Antihuman  lymphocyte sera  (ALS),  used  to  coat target  cells for the  ADCC 
reaction,  was  prepared  by  injecting  adult  male  rabbits  intravenously  with  purified  human 
lymphocytes (3 x  10  e) on three occasions at 1-wk intervals and bleeding at 6 wk. The preparation 
and iodination of rabbit antihuman Fab has been previously described  (5,  15). Antieera against 
sheep  erythrocytes  were prepared  by  immunizing adult  rabbits  with sheep  erythrocytes  (108) 
(Microbiological Associates,  Bethesda,  Md.)  intravenously three times at 0,  1,  and 4 wk,  with 
bleeding at 6 wk. Fetal calf serum was obtained from Microbiological Associates. All serum were 
heat inactivated at 56°C for 45 min. 
Analysis of Surface Properties of Human Lymphocyte Subsets.  SIg was detected with fluores- 
ceinated rabbit antihuman Fab in the direct fluoresceinated antibody technique (15). The percent- 
age of lymphocytes forming spontaneous rosettes with sheep erythrocytes (E rosettes) (Microbio- 
logical Associates)  and  sheep  erythrocytes  coated with  antisheep  erythrocyte  antibody  and  C 
components  1,  4,  2,  and  3  (EAC  cells)  (Cordis  Laboratories,  Miami,  Fla.)  was  determined  as 
previously described  (12). For determination  of EA-rosetting cells a  0.5%  suspension  of sheep 
erythrocytes  was  incubated  with  a  1:10 dilution  of antisheep  erythrocyte  antibody  at  room 
temperature for 1 h followed by washing three times in Media 199 with 5% fetal calf serum. The 
resulting EA reagent was brought to a 0.5% concentration and incubated with 2 x  105 lymphocytes 
in 0.1 cm  3 at room temperature for 1 h. For E, EA, and EAC rosette determinations a lymphocyte 
having three ormore adherent erythrocytes was counted as having formed a  rosette. 
Fractionation of Lymphocytes into T, B, and Null Subpopulations.  Human peripheral blood 
mononuclear cells were isolated from normal volunteers by Ficoll-Hypaque density centrifuga- 
tion.  Whole populations of mononuclear cells were separated into SIg-positive (>98%) and SIg- 
negative  (<2%)  subpopulations  by Sephadex  G-200  antihuman  Fab  column  immunoabsorbent 
chromatography as previously described (15). The nonimmunoglobulin-bearing lymphocyte popu- 
lation  was  further  fractionated  into  E  rosette-positive and  E  rosette-negative subsets  by the 
formation  and  subsequent  depletion  of E  rosette-forming cells over a  Ficoll-Hypaque density 
gradient (12). The E rosette-depleted subpopulation (Null cells) contained less than 2% Ig-positive 
cells, less than  4% E  rosette-positive cells, and varied between 30 and 60% EAC-positive cells. 
Similarly, highly purified T cells (->92% E positive) were prepared by EAC depletion of the SIg- 
negative population (5, 12). All cell populations were washed four times and resuspended in final 
media (Media 199) with 10% fetal calf serum, 200 mM glutamine, and 1% penicillin-streptomycin 
(Microbiological Associates). 
ADCC.  The ADCC  assay has  been previously  reported (5).  In  brief,  purified  mononuclear cells 
were coated  with ALS (1/50  dilution)  and used as  target cells.  1.5 × 105  cells  were labeled with 0.15 
ml of p~Cr]sodium chromate (292 pCi/ml) (New England Nuclear, Boston, Mass.), for 30 min at 
37°C with slow, continuing inversion. The antibody-labeled target cells  and control cells (not 
treated with antibody) were washed twice to remove excess, nonbound antibody and brought to a 
final  concentration of 105 cells/ml  in final  media. Labeled target cells  were pipetted in triplicate CHESS,  EVANS,  HUMPHREYS,  8TROMINGER,  AND  SCHLOSSMAN  115 
into 10 x 75 mm tubes. The appropriate suspension of killer cells (0.2 cm  3) was added and the tubes 
centrifuged at 400 g  for 10 rain and incubated at 37°C in a  5% CO2 humid atmosphere overnight. 
After incubation, 1.7 ml of fresh media was added to each tube and the tubes were centrifuged at 
400 g  for 10 rain and 1 ml of supernatant solution was removed and assayed in a gamma counter. 
Maximal stCr released was determined after freeze-thawing target cells. Percent cytotoxicity was 
determined by the formula: 
slCr released by experimental -  ~lCr released from control 
Percent cytotoxicity =  5,Cr released by freeze-thaw -  s~Cr released from control  " 
Determination oflg Production in Cell Culture.  Polyvalent Ig synthesis was determined by a 
sandwich radioimmunoassay (13). Briefly, unfractionated and fractionated cells were incubated in 
final media at 37°C  in a  5% CO2 humid atmosphere for 6 days. Supernatant solutions were then 
analyzed for Ig content by reaction with antihuman Fab covalently coupled to Sephadex G-25. To 
0.2 ml of the coupled Sephadex G-25 anti-Fab beads were added in triplicate either 0.5 ml of tissue 
culture supernates, 0.5 ml of final media or 0.5 ml of varying concentrations of human Ig (Miles 
Laboratories Inc.,  Miles Research Products, Elkhart, Ind.).  After 90 min incubation at room 
temperature, the  beads  were washed three times and 0.1  ml of  ~251-1abeled  rabbit  antihuman Fab 
was  added. ARer an  additional  I  h incubation,  the  tubes  were  washed  three  times  and  counted  in  a 
gamma counter.  After  subtraction  of  background  counts (tubes  with  media  alone)  the  amount of  Ig 
was determined by reference to a standard curve.  As previously reported, ~2Sl  bound varied 
linearly  with  the log  concentration  of  human Ig  present in  the  range  of  Ig  concentration  between 
10 and 500 ng (13). 
Physical  Depletion  of  Cells  on Goat  A ntirabbit  Fab Cellular  Immunoabsorbents.  Purified  goat 
antirabbit  Fab (G/R Fab)  was  prepared, passed  through  a human Ig-Sepharose column to  remove 
cross-reacting  antibodies to human Ig, and covalently linked to Sephadex G-200 by methods 
identical  to  those  used  for  the  preparation of  antihuman Fab  and  antimouse  Fab columns (15,  16). 
The G/R Fab cellular  immunoabsorbent was used to deplete  human lymphocyte subpopulations 
which had specific  rabbit  antibodies  bound to their  surface.  Thus, 60 × 106  cells  were incubated 
with either heat-inactivated normal rabbit serum (NRS) (dilution  1/20)  or rabbit anti-p23,30 
(dilution 1/20)  for 1 h at room temperature.  Cells  were washed four times, in final  media 
containing 2.5 mm  EDTA  and applied to the G/R Fab columns using a flow rate of  5 ml/min. 
Control cells  incubated  in the presence of  NRS and then washed were not  retained. 
Results 
The Effector Cells and Quantitative Parameters of  ADCC.  The quantitative 
parameters and effector lymphocyte populations important in ADCC are illus- 
trated  in  Fig.  1.  Using optimal  concentrations of antilymphocyte sera  (1:50 
dilution) added to  5;Cr-labeled human lymphocyte target cells, maximal cell 
lysis is usually seen with an effector to target cell ratio of 40:1. Significant lysis 
is usually present at ratios as low as five effector cells to one target cells. In 
previous  studies,  it  was  shown that  most of the ADCC  activity within the 
peripheral lymphocyte population is due to the subset of lymphocytes which are 
E rosette negative and do not bear immunoglobulins on their surface. A repre- 
sentative experiment showing these points is depicted in Fig. 1. As,can be seen, 
experimental procedures which deplete either the E  rosette-positive cells  (T 
cells) or the SIg-bearing cells from an unfractionated lymphocyte population 
increases ADCC activity. The predominant ADCC effector resides in the SIg- 
negative, E  rosette-negative subset. In contrast, purified populations of either 
Ig-positive  B  cells  or  E  rosette-positive  T  cells  are  relatively inefficient or 
inactive in this ADCC system (5). 
Depletion of ADCC Effector Activity by Removal of  p23,30-Bearing Lympho- 
cytes.  Since previous studies have shown that approximately 15-30%  of cells 116  FUNCTIONAL  PROPERTIES  OF  A  B-CELL-SPECIFIC  ANTISERUM 
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FIG.  1.  Antibody-mediated cellular c~otoxic activity of isolated human lymphocyte sub- 
populations. Effector cells  were incubated with 104 s~Cr-labeled antibody-coated lympho- 
cytes for 16 h and the results  expressed as percent  cytotoxicity  of  triplicate  cultures at each 
effector  to  target ratio.  The freeze-thaw  value  was 313 _+ 16  and the  spontaneous release was 
56 _+ 13. The 51Cr released from target cells  not incubated with antibody was virtually 
identical  to the spontaneous release. 
within the Ig-negative, E rosette-negative fraction of human lymphocytes bear 
p23,30  on their surface, it was important to know whether it was those cells 
which were the effector cells of ADCC. In initial experiments we asked whether 
treatment of effector cell populations with antibody p23,30 in the presence of C 
could deplete ADCC activity. Lymphocyte subsets were incubated in the pres- 
ence of  media or of  NRS (dilution 1:20) or of  anti-p23,30 serum each with C for 2 h 
at room temperature. All cell populations were washed exhaustively and tested 
for their ability to trigger the ADCC reaction. The results of a number of such 
experiments on a variety of effector lymphocyte populations is shown in Table I. 
In every experiment, a  single treatment of cells with anti-p23,30 serum and C 
diminished and in some cases totally eliminated ADCC reactivity. As can be 
seen, NRS had minimal to no effect relative to the media and C controls. 
Whether the p23,30  antigen was important for the triggering of the ADCC 
reaction was addressed in the next series of experiments in which cells were 
incubated without a C source either in the presence of NRS or anti-p23,30 serum 
and tested for ADCC activity. As shown in Table II, the presence of anti-p23,30 
serum but not NRS during the effector phase abrogated ADCC reactivity. These 
results suggested that not only is p23,30 antigen present on ADCC effector cells, 
but this antigen may also be important for the initiation of ADCC. 
Further evidence that the ADCC  effector cell bore p23,30  antigen was ob- 
tained in studies in which lymphocyte effecter cell populations were incubated 
with anti-p23,30 serum and then depleted by passage through Sephadex G-200 
antirabbit Fab immunoabsorbent columns. In these experiments, the immuno- 
globulin-negative, E rosette-negative cell population (Null cell) was incubated 
either in the presence of  anti-p23,30 serum or NRS at dilutions of 1-20 for 1 h and 
passed through an antirabbit Fab  immunoabsorbent column. Approximately 
30% of the cells treated with anti-p23,30 serum were retained on the column. By 
contrast only 7% of cells incubated in NRS were retained. More important, as CHESS,  EVANS,  HUMPHREYS~  STROMINGER,  AND  SCHLOSSMAN  117 
TABLE  I 
Depletion of ADCC Effector Activity by C-Mediated Lysis of  p23,30-Bearing  Cells 
Effector/ 
Isolated lymphocyte pop- 
ulation*  target ra- 
tio 
%  Cytotoxicity$ 
Media  +  C  NRS  +  C  Anti-p23,30  +  C§ 
Unfractionated  lympho-  40/1  30.0  ±  2.6  28.7  ±  2.3  12.5  ±  1.1 
cytes  20/1  17.3  ±  1.8  16.5  _  3.1  3.0  ±  0.2 
Ig negative (T +  Null)  40/1  29.3  ±  2.7  25.2  ±  6.1  6.1  ±  7.2 
20/1  15.7  _  1.3  18.6  ±  1.3  0.5  _  0.2 
Ig negative (T +  Null)  40/1  56.3  +_ 2.3  48.6  ±  3.1  1.7  _+ 0.6 
20/1  18.5  ±  2.7  15.3  ±  2.7  0.3  ±  0.1 
Ig negative (T  +  Null)  40/1  20.3  _+ 3.5  23.5  ±  2.6  3.4  ±  2.1 
20/1  13.6  +_ 4.1  12.8  ±  1.7  2.9  _+  1.7 
Ig  negative,  E  rosette  40/1  57.4  ±  3.2  59.6  ±  2.1  18.9  ±  4.3 
negative (Null)  5/1  23.4  _+  5.6  20.6  _+  1.0  3.2  ±  1.7 
Ig  negative,  E  rosette  40/1  33.8  ±  6.2  29.6  ___ 3.2  2.6  ±  1.4 
negative (Null)  5/1  21.7  _  2.5  18.7  _+ 4.1  0.7  _  1.2 
* Effector lymphocyte populations in these six experiments were either Ficoll-Hypaque-purified 
lymphocytes (unfractionated), lymphocytes not retained on anti-Fab columns (T +  Null), or cells 
not retained on anti-Fab columns and subsequently E  depleted  (Null). 
4  x  105  or  2  ×  105  effector  cells  were  added  to  the  10  ~ ~lCr-labeled  antibody-coated  target 
lymphocytes  and  5~Cr  released  into  the  supernatant  solutions  from  triplicate  cultures  was 
assayed. The results are expressed as mean percent cytotexicity ___ SEM. The freeze-thaw value 
averaged 323.5  _  12.6 and the spontaneous release was 45  ±  2.7. 
§ Effector  lymphocytes were  incubated  with  either  media,  NRS,  or  anti-p23,30  serum  at room 
temperature for 1 h  and treated  with rabbit C  for 1 h  at 37°C. 
shown  in  Fig.  2,  the  nonretained  anti-p23,30-treated  cells  were  inactive  in 
ADCC, while the nonretained NRS-treated cells were fully active. 
Antibody to p23,30 Antigen Does  not Inhibit EA Rosette Formation.  One 
interpretation for the above results is that anti-p23,30 serum exhibits ADCC by 
binding to the Fc receptor. In order to explore this possibility, we reasoned that 
if p23,30  is  reacting  with  the  Fc  receptor  on  the  ADCC  effector  cell,  then 
incubation of this antibody with the effector cells should inhibit binding to EA 
cells, a function which is known to depend on Fc receptors. Thus, lymphocytes 
were incubated with anti-p23,30 serum or NRS at dilutions of 1:20. Afterwards, 
these cells were reacted with EA cells and the percentage of cells forming EA 
rosettes was enumerated. As shown in Table III, the percentage of EA-rosetting 
cells with either no treatment,  NRS, or anti-p23,30 serum treatment remained 
constant. These results indicate that anti-p23,30 serum does not bind to the Fc 
receptor. 
Depletion  of p23,30-Positive  Cells  Eliminates Antibody-Forming Precursor 
Cells.  We then  determined  whether  the  p23,30-positive  cells  within  the  Ig- 
negative, E rosette-negative subset was the same subpopulation of cells which 
could maturate in cell culture into Ig-positive, immunoglobulin-secreting cells. 
Unfractionated  lymphocytes,  T  cells,  Ig-positive  cells,  and  Null  cells  were 118  FUNCTIONAL  PROPERTIES  OF  A  B-CELL-SPECIFIC  ANTISERUM 
TABLE  II 
Specific Binding of Anti-p23,30 to Effector Lymphocytes Inhibits ADCC 
Isolated effector population* 
Effector/target 
ratio 
% Cytotoxicity 
NRS  Anti-p23,305 
Unfractionated lymphocytes  40/1  32.2  ±  3.5  12.6  ±  2.1 
20/1  25.9  ±  1.8  7.2  ±  0.7 
Ig negative (T  +  Null)  40/1  20.3  _+  3.5  3.4  ±  1.5 
20/1  13.6  ±  2.6  2.9  ±  0.6 
Ig negative (T  +  Null)  40/1  29.0  ±  2.6  6.1  ±  3.7 
20/1  10.0  ±  3.5  5.7  ±  2.1 
Ig negative (T +  Null)  40/1  32.3  ±  5.7  0.8  ±  1.2 
20/1  5.7  _+  1.3  0.6  ±  0.7 
Ig negative, E  rosette nega-  40/1  75.9  _+  3.2  12.6  +  1.3 
tive (Null)  20/1  43.5  ±  6.5  1.7  ±  5.8 
* Effector lymphocyte populations were  isolated in  separate experiments as  indicated in  the 
Materials and Methods and in Table I. 
* Cells were incubated with NItS (1/20 dilution) or anti-p23,30 serum (1/20 dilution), washed three 
times, and assayed for ADCC on 51Cr-labeled, antibody-coated target cells. 
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FIG.  2.  Specific depletion of p23,30-bearing cells on G/R Fab immunoabsorbent columns 
eliminates ADCC activity. 
incubated with either NRS or anti-p23,30  serum in the presence of C, washed, 
and placed in cell culture for 6 days in a 5% CO2 atmosphere at 37°C. Supernates 
were analyzed for Ig. As seen in Table IV, both Ig-positive cells and a subset of 
cells within the Ig-negative, E rosette-negative subset of human lymphocytes 
(Null cells) do have the capacity to secrete immunoglobulin during cell culture 
(Table IV).  By contrast,  isolated T-cell populations  do  not secrete Ig.  More 
important, prior treatment of the Ig-secreting cell populations with anti-p23,30 
and  C  completely abrogated  the  ability  to  secrete  immunoglobulin in  cell 
culture.  Thus,  the  p23,30-positive,  E  rosette-negative, Ig-negative subset  of 
lymphocytes is important both with respect to ADCC function and with respect 
to Ig synthesis. CHESS,  EVANS,  HUMPHREYS,  STROMINGER,  AND  SCHLOSSMAN 
TABLE III 
Effect of Anti-p23,30 on EA Rosette Formation 
119 
Cell population 
% EA rosette-forming  cells 
Control NRS  Anti-p23,30* 
Unfractionated  23 --+ 2  17 __+ 3 
Unfractionated  25 ± 1  16 _+ 2 
Unfractionated  34 ± 4  30 -~ 5 
Unfractionated  20 -+ 3  27 -  5 
Ig-positive lymphocytes (B cells)  89 ± 3  82 ± 6 
Ig-negative lymphocytes (T + Null cells)  12 ± 2  9 -~ 1 
Ig-negative,  E  rosette-negative  lympho-  72 _+ 3  63 ± 7 
cytes (Null cells) 
* Unfractionated  lymphocytes and isolated populations were treated  with either NRS (1/20 dilu- 
tion) or anti-p23,30 serum (1/20 dilution) for 1 h at room temperature  and subsequently assayed 
for the percent EA-rosetting cells. 
TASLE  IV 
Inhibition of Ig Synthesis In Vitro by Pretreatment with Anti-p23,30* 
Cell population  Media  NRS  Anti-p23,30 
Exp. 1 
Exp. 2 
Unfractionated cells  200  172  <10 
T cells  <10  <10  <10 
Ig  + B cells  430  385  26 
Null cells (Ig-E-)  360  300  <10 
Unfractionated cells  137  143  <10 
T cells  <10  <10  <10 
B cells  230  265  33 
Null cells  195  185  22 
* Unfractionated  lymphocytes and isolated populations were treated  with media, NRS, or anti- 
p23,30 serum and then with C, as in Table I. Cells were then incubated in final media for 6 days 
at 37°C in a 5% CO~ humid environment and supernatant solutions were analyzed for nanograms 
of secreted Ig by 125I-labeled anti-Fab  radioimmunoassay. 
Discussion 
The  anti-p23,30  serum  is  valuable  for  the  analysis  of human  lymphocyte 
functions both because it possesses a  unqiue cellular specificity (i.e., reactivity 
with 100% ofIg-positive B cells and approximately 20% of Ig negative, E rosette- 
negative [Null] cells and not with T cells) and because of its similarity to murine 
anti-Ia sera  (14). 
In  the  present  study  we  utilized  anti-p23,30  serum  to  explore  further  the 
functional properties of the surface Ig-negative, E  rosette-negative  (Null  cell) 
subset of human lymphocytes. In earlier  studies  it has  been  shown that this 
population contains  most of the  ADCC activity present  in  human peripheral 
blood  (5).  Moreover,  a  subset  of this  population  has  been  shown  to  develop 
surface immunoglobulins in cell culture and to develop the capacity to secrete 
immunoglobulins  in  vitro  (13).  The  question  of whether  the  two  functional 
properties of the Ig-negative, E  rosette-negative  (Null) subset of lymphocytes, 
that is,  ADCC and Ig synthesis,  resides  within the same subset of cells  were 
addressed in the experiments presented above. 120  FUNCTIONAL  PROPERTIES  OF  A  B-CELL-SPECIFIC  ANTISERUM 
The following points emerge from these studies: (a)  The human lymphocyte 
which functions as the effector cell in ADCC bears the p23,30 antigen. Depletion 
of cells bearing p23,30 from either  the  Ig-negative,  E  rosette-negative  (Null) 
subset or alternatively,  from unfractionated human lymphocytes by either  C- 
mediated  lysis  or  by  depletion  over  immunoabsorbent  columns,  eliminates 
ADCC  reactivity.  (b)  Exposure  of the  p23,30  antigen  is required  for  ADCC 
function since binding of anti-p23,30 serum to the effector cell surface inhibits 
ADCC. That this effect was not due to binding of anti-p23,30  serum to the Fc 
receptor was shown in studies which demonstrates that anti-p23,30 serum did 
not inhibit EA rosette formation.  Moreover, in previous studies it was shown 
that the anti-p23,30  serum does not inhibit the binding of aggregated gamma 
globulin to the cell surface,  another function dependent on Fc receptors  (14). 
Since Fc receptors are known to be necessary for ADCC, these results suggest 
that at least two distinct sites, Fc and p23,30, are involved in this form of cell- 
mediated  lysis.  (c)  Depletion  of cells bearing  p23,30  from  an  unfractionated 
population of cells, from Ig-positive B cells and from purified populations of Ig- 
negative,  E  rosette-negative  (Null)  cells  completely abrogates  the  ability  of 
these cells to secrete immunoglobulin during cell culture. Thus, all Ig-secreting 
peripheral lymphocytes bear p23,30 antigen. Taken together, these data provide 
evidence  that  the  ADCC  and  Ig-synthetic  functions  present  within  the  Ig- 
negative, E  rosette-negative (Null) subset of human lymphocytes reside in the 
same population of cells bearing the antigen p23,30. 
The simplest interpretation of these results is that the ADCC effector lympho- 
cyte and  the  Ig-synthesizing  cell  have  differentiated  along  B-cell pathways. 
Consistent  with  this  view  is  the  evidence  that  the  ADCC  effector  cell,  in 
addition  to  bearing  p23,30  is  known  to  have  other  surface  determinants  in 
common with B cells such as the Fc and C receptors (9, 11). Moreover, the ADCC 
effector lymphocyte is nonphagocytic and does not bear antigens or receptors in 
common with  T  cells.  We cannot  exclude the possibility that  another  as yet 
undefined receptor on the surface of the ADCC effector cell may distinguish this 
subset from other B cells. The fact that Ig-positive B cells which are retained on 
anti-Fab immunoabsorbent columns, are relatively inefficient in ADCC suggest 
that this ADCC function defines a distinct small subset of B cells. Whether this 
subset of B cells is unique with respect to either the control of immunoglobulin 
synthesis or with respect to the type of immunoglobulin produced, or in fact with 
respect to other biologic functions,  remains  to be determined.  However, it is 
clear that all ADCC effector subsets of lymphocytes bear the p23,30 antigen. 
The precise role of p23,30  in  either  immunoglobulin  synthesis or ADCC  is 
unknown.  The  structural  and  functional  similarities  of p23,30  to  murine  Ia 
antigens as documented in the accompanying manuscript are of interest with 
respect to recent evidence that Ia antigens and Fc receptors appear to be closely 
associated on the cell surface (17). One can thus envision a model in which the 
triggering  of ADCC is dependent on two signals:  one being recognition of the 
antibody-coated target cell by the Fc receptor and the other, the activation of the 
nearby p23,30 antigen by either the target cell or by the activated Fc receptor 
itself. This mechanism would of course be analogous to the triggering of B cells 
towards their differentiation into antibody-secreting cells, a function thought to CHESS,  EVANS,  HUMPHREYS,  STROMINGER,  AN])  SCHLOSSMAN  121 
require at least two signals. Since the Ia antigens are thought to be important in 
the facilitation of cell-cell interactions as for example, during T, B cooperation, 
(18), it is possible that these antigens may have a  broader biologic function in 
other cell-cell interaction  involving B cells such as occurs in ADCC. 
Summary 
Rabbit antisera to the human B-cell-specific surface antigen complex, p23,30, 
was  used  to  define  further  the  functional  heterogeneity  of isolated  human 
lymphocyte subpopulations.  Specific depletion of p23,30-bearing cells from Ig- 
negative cell populations and Ig-negative, E rosette-negative (Null) populations 
by either complement-mediated lysis or by physical separation on goat antirab- 
bit Fab immunoabsorbent columns, eliminates the antibody-dependent cellular 
cytotoxic (ADCC) function.  Furthermore,  binding of anti-p23,30  serum to the 
effector  cell  surface  inhibits  ADCC  but  does  not  interfere  with  EA  rosette 
formation. Apparently p23,30 represents a cell surface site which is distinct from 
the Fc receptor but which is important  in the triggering of ADCC. 
In addition, depletion of p23,30-bearing cells from unfractionated cell popula- 
tions, Ig-positive B-cell populations and Ig-negative,  E  rosette-negative  (Null) 
populations eliminates the capacity of these populations to secrete immunoglob- 
ulin  during  subsequent  culturing.  Thus  beth  the  Ig-secreting  cells  and  the 
ADCC effector cells within the Ig-negative, E rosette-negative (Null) population 
reside in the same population of cells which bears the p23,30 antigen. 
Received for publication 27 January 1976. 
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